share_log

康辰药业(603590.SH)：拟推437.5万股限制性股票激励计划

Kangchen Pharmaceutical (603590.SH): Proposes to launch a restricted stock incentive plan for 4.375 million shares

Gelonghui Finance ·  Jul 31, 2023 11:27

Gelonghui, July 31? Kangchen Pharmaceutical (603590.SH) announced the 2023 restricted stock incentive plan. The number of restricted shares to be granted under this incentive plan is 4.375 million shares, accounting for 2.734% of the company's total share capital of 160 million shares at the time of the announcement of the draft incentive plan. Among them, 3.5 million shares were granted for the first time, accounting for 2.188% of the company's total equity of 160 million shares at the time of the announcement of the draft incentive plan; 875000 shares were reserved, accounting for 0.547% of the company's total share capital of 160 million shares at the time of the announcement of the draft incentive plan, and the reserved portion accounted for 20.00% of the total rights and interests granted this time.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment